EBOS was poised to buy vet and pet food chain Greencross in $3.75b deal.
The proposal fell over after lukewarm investor support.
EBOS says no deal will proceed.
A $3.75 billion deal for pharmaceutical and animal goods distributor EBOS to buy pet food and veterinary business Greencross has collapsed at the last minute after tepid investor support for funding the acquisition.
“A transaction will not proceed,” EBOS, listed on the Australian and New Zealand stock exchanges, told investors on Wednesday.
Loading...
Liam Walsh writes on investigations and companies with The Australian Financial Review. He has won multiple media awards, worked in Japan and is now based in Brisbane. Email Liam at liam.walsh@afr.com.au
